TAXES ON INCOME (Schedule of Deferred Tax Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
In respect of:
Research and development expenses	$ 3,055	$ 4,625
Other timing differences	452	(1,387)
Net operating loss carry forwards	50,014	51,472
Valuation allowance	(50,665)	(51,618)	$ (58,550)
Total net deferred tax assets	$ 2,856	$ 3,092